PSC Prepares to Launch COVID-19 Clinical Trial – You Can Help
Our human stem cell company, Personalized Stem Cells, Inc. (PSC), recently announced that they filed a request with the FDA for expedited review of an Investigational New Drug (IND) application for the treatment of COVID-19 patients with stem cells. PSC was asked by the White House Coronavirus Task Force to apply for expedited review through a new FDA program called the Coronavirus Therapeutic Accelerator Program (CTAP). CTAP was launched to help expedite the approval process of clinical trials for promising COVID-19 therapies.
Stem Cells for COVID-19
Recent studies evaluating the effects of stem cell therapy in COVID-19 patients have come out of China and Israel showing strikingly positive results. Stem cells have anti-inflammatory properties and the ability to reduce scar tissue formation. Stem cell therapy has the potential to reduce the serious lung complications that occur as a result of infection with COVID-19. The goal of treatment is to reduce time spent in the ICU, reduce ventilator needs, and increase chances of survival for seriously ill COVID-19 patients.
PSC has scaled up production of stem cells in their FDA-inspected facilities to be ready to provide stem cell treatments upon FDA approval. If approved, the initial COVID-19 clinical trial, termed “CoronaStem 1,” will provide treatment for twenty hospitalized COVID-19 patients with serious complications. The first trial will be conducted in a limited number of local San Diego hospitals. PSC anticipates additional approvals and potential compassionate use in the future to allow for many more patients to be treated.
How can you help?
As a small business, PSC is utilizing their own resources to ramp up stem cell production. However, supplies and laboratory technicians are necessary to further increase production of stem cells. PSC plans to provide stem cell treatments to COVID-19 patients at no cost to the patient which requires additional money to pay the doctors, nurses and other healthcare workers who will be performing the clinical trial. Thus, PSC is reaching out to the public for donations to help in this fight against COVID-19. Your tax-deductible donation will allow PSC to provide stem cell treatments for as many COVID-19 patients as possible. All donations will go towards increasing stem cell production and paying doctors, nurses, technicians, and all those involved in performing the medical procedures for the clinical trial.
While the COVID-19 pandemic has impacted us all, many of us are looking for ways in which we can help. PSC has partnered with the San Diego Foundation, a 501c3 organization, to collect tax-deductible donations to further PSC’s efforts. Learn more about how your donation can help PSC fight COVID-19.
You can make a difference! Click here to donate today.